Molecular Hydrogen as a Neuroprotective Agent
- PMID: 27281176
- PMCID: PMC5412697
- DOI: 10.2174/1570159x14666160607205417
Molecular Hydrogen as a Neuroprotective Agent
Abstract
Oxidative stress and neuroinflammation cause many neurological disorders. Recently, it has been reported that molecular hydrogen (H2) functions as an antioxidant and anti-inflammatory agent. The routes of H2 administration in animal model and human clinical studies are roughly classified into three types, inhalation of H2 gas, drinking H2-dissolved water, and injection of H2-dissolved saline. This review discusses some of the remarkable progress that has been made in the research of H2 use for neurological disorders, such as cerebrovascular diseases, neurodegenerative disorders, and neonatal brain disorders. Although most neurological disorders are currently incurable, these studies suggest the clinical potential of H2 administration for their prevention, treatment, and mitigation. Several of the potential effectors of H2 will also be discussed, including cell signaling molecules and hormones that are responsible for preventing oxidative stress and inflammation. Nevertheless, further investigation will be required to determine the direct target molecule of H2.
Similar articles
-
Molecular hydrogen as a novel antioxidant: overview of the advantages of hydrogen for medical applications.Methods Enzymol. 2015;555:289-317. doi: 10.1016/bs.mie.2014.11.038. Epub 2015 Jan 21. Methods Enzymol. 2015. PMID: 25747486 Review.
-
Molecular hydrogen as a preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine.Pharmacol Ther. 2014 Oct;144(1):1-11. doi: 10.1016/j.pharmthera.2014.04.006. Epub 2014 Apr 24. Pharmacol Ther. 2014. PMID: 24769081 Review.
-
Molecular hydrogen affords neuroprotection in a translational piglet model of hypoxic-ischemic encephalopathy.J Physiol Pharmacol. 2016 Oct;67(5):677-689. J Physiol Pharmacol. 2016. PMID: 28011948
-
Effects of Molecular Hydrogen Assessed by an Animal Model and a Randomized Clinical Study on Mild Cognitive Impairment.Curr Alzheimer Res. 2018 Mar 14;15(5):482-492. doi: 10.2174/1567205014666171106145017. Curr Alzheimer Res. 2018. PMID: 29110615 Free PMC article. Clinical Trial.
-
Hydrogen ameliorates chronic intermittent hypoxia-induced neurocognitive impairment via inhibiting oxidative stress.Brain Res Bull. 2018 Oct;143:225-233. doi: 10.1016/j.brainresbull.2018.09.012. Epub 2018 Sep 20. Brain Res Bull. 2018. PMID: 30243887
Cited by
-
Molecular Hydrogen Neuroprotection in Post-Ischemic Neurodegeneration in the Form of Alzheimer's Disease Proteinopathy: Underlying Mechanisms and Potential for Clinical Implementation-Fantasy or Reality?Int J Mol Sci. 2022 Jun 13;23(12):6591. doi: 10.3390/ijms23126591. Int J Mol Sci. 2022. PMID: 35743035 Free PMC article. Review.
-
Hydrogen-rich water and caffeine for alertness and brain metabolism in sleep-deprived habitual coffee drinkers.Food Sci Nutr. 2021 Jul 19;9(9):5139-5145. doi: 10.1002/fsn3.2480. eCollection 2021 Sep. Food Sci Nutr. 2021. PMID: 34532023 Free PMC article.
-
Effects of hydrogen gas inhalation on L-DOPA-induced dyskinesia.Brain Behav Immun Health. 2023 Apr 8;30:100623. doi: 10.1016/j.bbih.2023.100623. eCollection 2023 Jul. Brain Behav Immun Health. 2023. PMID: 37096172 Free PMC article.
-
Effects of hydrogen water and psychological treatment in a sample of women with panic disorder: a randomized and controlled clinical trial.Health Psychol Res. 2022 May 30;10(3):35468. doi: 10.52965/001c.35468. eCollection 2022. Health Psychol Res. 2022. PMID: 35774917 Free PMC article.
-
Hydrogen-rich water ameliorates neuropathological impairments in a mouse model of Alzheimer's disease through reducing neuroinflammation and modulating intestinal microbiota.Neural Regen Res. 2022 Feb;17(2):409-417. doi: 10.4103/1673-5374.317992. Neural Regen Res. 2022. PMID: 34269217 Free PMC article.
References
-
- Emerit J., Edeas M., Bricaire F. Neurodegenerative diseases and oxidative stress. Biomed. Pharmacother. 2004;58(1):39–46. [http:// dx.doi.org/10.1016/j.biopha.2003.11.004]. [PMID: 14739060]. - PubMed
-
- Ohsawa I., Ishikawa M., Takahashi K., Watanabe M., Nishimaki K., Yamagata K., Katsura K., Katayama Y., Asoh S., Ohta S. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat. Med. 2007;13(6):688–694. [http://dx.doi.org/10.1038/nm1577]. [PMID: 17486089]. - PubMed
-
- Fukuda K., Asoh S., Ishikawa M., Yamamoto Y., Ohsawa I., Ohta S. Inhalation of hydrogen gas suppresses hepatic injury caused by ischemia/reperfusion through reducing oxidative stress. Biochem. Biophys. Res. Commun. 2007;361(3):670–674. [http://dx.doi.org/10.1016/j.bbrc.2007.07.088]. [PMID: 17673169]. - PubMed
-
- Hayashida K., Sano M., Ohsawa I., Shinmura K., Tamaki K., Kimura K., Endo J., Katayama T., Kawamura A., Kohsaka S., Makino S., Ohta S., Ogawa S., Fukuda K. Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochem. Biophys. Res. Commun. 2008;373(1):30–35. [http://dx.doi.org/10.1016/j.bbrc.2008.05.165]. [PMID: 18541148]. - PubMed
-
- Ohta S. Molecular hydrogen as a preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine. Pharmacol. Ther. 2014;144(1):1–11. [http://dx.doi.org/ 10.1016/j.pharmthera.2014.04.006]. [PMID: 24769081]. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical